Federated Hermes’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-70,276
| Closed | -$1.3M | – | 2258 |
|
2023
Q3 | $1.3M | Sell |
70,276
-101,474
| -59% | -$1.88M | ﹤0.01% | 1031 |
|
2023
Q2 | $1.9M | Buy |
171,750
+69,004
| +67% | +$763K | ﹤0.01% | 970 |
|
2023
Q1 | $1.38M | Buy |
102,746
+101,619
| +9,017% | +$1.36M | ﹤0.01% | 1068 |
|
2022
Q4 | $13.9K | Buy |
1,127
+1,057
| +1,510% | +$13.1K | ﹤0.01% | 1834 |
|
2022
Q3 | $1K | Buy |
+70
| New | +$1K | ﹤0.01% | 2109 |
|
2022
Q1 | – | Sell |
-56,198
| Closed | -$915K | – | 2363 |
|
2021
Q4 | $915K | Buy |
+56,198
| New | +$915K | ﹤0.01% | 1314 |
|
2020
Q2 | – | Sell |
-1
| Closed | -$1K | – | 2406 |
|
2020
Q1 | $1K | Sell |
1
-96,983
| -100% | -$97M | ﹤0.01% | 2177 |
|
2019
Q4 | $12M | Buy |
+96,984
| New | +$12M | 0.03% | 555 |
|
2019
Q3 | – | Sell |
-977
| Closed | -$78K | – | 2309 |
|
2019
Q2 | $78K | Sell |
977
-139,588
| -99% | -$11.1M | ﹤0.01% | 1633 |
|
2019
Q1 | $15.7M | Buy |
140,565
+118,264
| +530% | +$13.2M | 0.04% | 412 |
|
2018
Q4 | $2.25M | Sell |
22,301
-62,724
| -74% | -$6.32M | 0.01% | 982 |
|
2018
Q3 | $10.7M | Buy |
85,025
+78,260
| +1,157% | +$9.89M | 0.03% | 550 |
|
2018
Q2 | $568K | Buy |
6,765
+1,025
| +18% | +$86.1K | ﹤0.01% | 1392 |
|
2018
Q1 | $353K | Buy |
5,740
+5,008
| +684% | +$308K | ﹤0.01% | 1445 |
|
2017
Q4 | $43K | Sell |
732
-17
| -2% | -$999 | ﹤0.01% | 1681 |
|
2017
Q3 | $43K | Buy |
749
+138
| +23% | +$7.92K | ﹤0.01% | 1665 |
|
2017
Q2 | $74K | Sell |
611
-2,959
| -83% | -$358K | ﹤0.01% | 1610 |
|
2017
Q1 | $404K | Buy |
3,570
+914
| +34% | +$103K | ﹤0.01% | 1371 |
|
2016
Q4 | $289K | Sell |
2,656
-466
| -15% | -$50.7K | ﹤0.01% | 1434 |
|
2016
Q3 | $514K | Buy |
+3,122
| New | +$514K | ﹤0.01% | 1271 |
|
2014
Q1 | – | Sell |
-100,200
| Closed | -$6.84M | – | 1799 |
|
2013
Q4 | $6.84M | Hold |
100,200
| – | – | 0.02% | 547 |
|
2013
Q3 | $6.92M | Buy |
100,200
+200
| +0.2% | +$13.8K | 0.03% | 482 |
|
2013
Q2 | $4.48M | Buy |
+100,000
| New | +$4.48M | 0.02% | 610 |
|